US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Drug Discovery: market research reports

RSS Feeds

Drug Discovery market research reports and industry analysis

6  7  8  9    11    13  14  15  
Liver Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of liver cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 173 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 4,496
Lung Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of lung cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 304 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Melanoma Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... signaling pathways for the treatment of melanoma. The rational for this plethora of treatment strategies is based on our increasing understanding of the 235 drug targets that are included in this drug-pathway analyzing tool. No ...  |  read more...
USD 6,746
Neuroendocrine Tumors Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of neuroendocrine tumors. The rational for this plethora of treatment strategies is based on our increasing understanding of the 76 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 2,246
Pancreatic Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of pancreatic cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 255 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Peptides in Oncology: Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of more than 74 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 183 drug targets that are included ...  |  read more...
USD 6,746
Protein Kinase Inhibitors Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... 250 specific intracellular signaling pathways for the treatment of more than 131 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 250 drug targets that ...  |  read more...
USD 8,996
Renal Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of renal cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 194 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Alpha6 Beta4 Integrin Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... 385 Alpha6Beta4 integrin pathway targeting drugs in 1315 developmental projects in cancer. In addition, there are 2 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 167 drugs. ...  |  read more...
USD 6,746
Angiogenesis in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... number of ceased drugs over the last years amount to another 180 drugs. Angiogenesis In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs ...  |  read more...
USD 6,746
Antibodies in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... for the second wave in the lucrative field of therapeutic antibodies. There are today 315 companies plus partners developing 701 antibody drugs in 1690 developmental projects in cancer. In addition, there are 8 suspended drugs ...  |  read more...
USD 6,746
Brain Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... deadly diseases in the developed world. While primary brain tumors are relatively rare, the chances of survival for patients with the disease are very low, even with the best treatment options currently available. There are ...  |  read more...
USD 6,746
Breast Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... and metastatic setting, the overall survival remains below five years. There are today 383 companies plus partners developing 534 drugs targeting breast cancer in development. In addition, there are 8 suspended drugs and the accumulated ...  |  read more...
USD 6,746
Calcium Signaling Pathway in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... suspended drug and the accumulated number of ceased drugs over the last years amount to another 103 drugs. Calcium Signaling Pathway In Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis ...  |  read more...
USD 6,746
Cancer Drugs in the FDA Fast Lane Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... of new drugs, ranging from Fast track (1988), Accelerated approval (1992), Priority review (1992) to the most recent Breakthrough therapy (2012). This pipeline update, Cancer Drugs in the FDA Fast Lane, gives a thorough account ...  |  read more...
USD 4,496
Cancer Stem Cells Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... development and cancer drugs which are inhibitors of the Hedgehog, Notch, and WNT Pathway. These developmental pathways are frequently activated in neoplasms, and particularly in the rare subpopulation of cancer stem cells. There are today ...  |  read more...
USD 6,746
Breast Cancer Drug Pathway Analyzer 2014
7/15/2014 | published by: BioSeeker Group AB
... intracellular signaling pathways for the treatment of breast cancer. The rational for this plethora of treatment strategies is based on our increasing understanding of the 290 drug targets that are included in this drug-pathway analyzing ...  |  read more...
USD 6,746
Cell Cycle Targeting in Cancer Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... suspended drugs and the accumulated number of ceased drugs over the last years amount to another 110 drugs. Cell Cycle Targeting In Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis ...  |  read more...
USD 6,746
Cellular Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... the accumulated number of ceased drugs over the last years amount to another 64 drugs. Cellular Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of ...  |  read more...
USD 4,496
Epigenetic Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... autoimmunity, diabetes, or neurological disorders. Recent research has identified the set of enzymes and chromatin-binding proteins responsible for regulating chromatin structure. These enzymes and binding proteins form the cell’s toolkit for epigenetic regulation by opening ...  |  read more...
USD 4,496
Fc Epsilon RI Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... of the alpha chain of Fc epsilon RI. The activation pathways are regulated both positively and negatively by the interactions of numerous signaling molecules. These mediators and cytokines contribute to inflammatory responses. There are today ...  |  read more...
USD 6,746
FSH Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... FSH signaling which continues further downstream. Activation of PKA leads to phosphorylation of transcription factors like cAMP response element binding protein(CREB) and brings about chromatin remodeling by phosphorylating histone H3. It also enhances the activity ...  |  read more...
USD 6,746
Gap Junctions in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... 'hemichannels', each containing six connexins, contributed by each neighboring cell. These channels permit the direct transfer of small molecules including ions, amino acids, nucleotides, second messengers and other metabolites between adjacent cells. Gap junctional communication ...  |  read more...
USD 6,746
Gene Therapy in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... the accumulated number of ceased drugs over the last years amount to another 97 drugs. Gene Therapy In Oncology Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of ...  |  read more...
USD 6,746
GnRH Signaling Pathway in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... and FSH. There are today 122 companies plus partners developing 151 GnRH signaling pathway targeting drugs in 615 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years amount ...  |  read more...
USD 6,746
6  7  8  9    11    13  14  15